NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 on The Pharmcast)

February 13, 2017 Jim Combs

This week on the Pharmcast, we talk with Dr. Joseph Lamendola on four New Drug Application (NDA) mistakes to avoid.

Dr. Lamendola is the former VP of U.S. Regulatory Affairs for Bristol-Myers Squibb and Schering-Plough, and now serves as the SVP and leader of YourEncore's Biopharma practice.

Joe has over 20 drug approvals to his name, so we ask Joe to share his life lessons on how to work with the FDA to receive NDA approval and ultimately get life-changing therapies to patients.

If you have topics you would like YourEncore to explore on future episodes of The Pharmcast, please email Pharmcast@yourencore.com with feedback or suggestions.

The Pharmcast is now available for download on iTunes, Google Play, and Stitcher. If you like what you hear, share it with your friends and write a review or give us a rating on your podcast store. 

Previous Article
Rewiring Our Brains: Thinking Differently About How We Approach the Gig Economy
Rewiring Our Brains: Thinking Differently About How We Approach the Gig Economy

I am a big movie buff.  It’s impossible not to be. I have two sons in the entertainment industry...

Next Article
Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)
Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

This week on The Pharmcast, we turn our attention to the topic of rare disease, and more speci...